Eurogenerics NV   Report issue

For profit Phase 4
Founded: Brussels Netherlands (1979)
Status: Left NME R&D (2012)

Organization Overview

First Clinical Trial
2002
NCT00221676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

alfarix (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1